Northeast Financial Consultants’s Dare Bioscience DARE Stock Holding History

Northeast Financial Consultants’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-167	Closed	-$16K	–	144
2017 Q1	$16K	Hold	167	–	–	0.01%	149
2016 Q4	$14K	Hold	167	–	–	0.01%	143
2016 Q3	$21K	Hold	167	–	–	0.01%	155
2016 Q2	$42K	Hold	167	–	–	0.02%	148
2016 Q1	$54K	Hold	167	–	–	0.03%	134
2015 Q4	$56K	Sell	167 -166	-50%	-$68.9K	0.03%	129
2015 Q3	$146K	Buy	333 +166	+99%	+$83.4K	0.07%	138
2015 Q2	$92K	Hold	167	–	–	0.04%	148
2015 Q1	$180K	Hold	167	–	–	0.08%	138
2014 Q4	$124K	Hold	167	–	–	0.07%	128
2014 Q3	$84K	Hold	167	–	–	0.05%	133
2014 Q2	$116K	Buy	+167	New	+$129K	0.07%	127

Other funds holding DARE

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northeast Financial Consultants's DARE Position: Q2 2017 in Review

Northeast Financial Consultants sold out of Dare Bioscience (DARE) in Q2 2017, closing a stake of 167 shares — an estimated $16K sold.

Northeast Financial Consultants first reported a position in DARE in Q2 2014 and held it in 12 quarters. The position peaked at $180K in Q1 2015. 19 funds tracked by Wall St. Rank hold DARE as of Q2 2017.

Northeast Financial Consultants reported no remaining Dare Bioscience position as of Q2 2017 after selling out during the quarter.
Northeast Financial Consultants sold 167 Dare Bioscience shares in Q2 2017, an estimated $16K.
Northeast Financial Consultants first reported a position in Dare Bioscience in Q2 2014 and held it in 12 quarters.
Northeast Financial Consultants's Dare Bioscience position peaked at $180K in Q1 2015.
19 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2017.

Based on Northeast Financial Consultants's 13F filing for Q2 2017, filed 26 Jul 2017.